Tuesday, 6 Jan 2026
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • VIDEO
  • ScienceAlert
  • White
  • man
  • Trumps
  • Watch
  • Season
  • Years
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock
Economy

Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock

Last updated: December 15, 2025 11:05 pm
Share
Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock
SHARE

The Chemours Company (NYSE:CC) is a top pick among the Best Small Cap Value Stocks to Buy. Despite reporting subpar earnings in its fiscal Q3 2025 results, the company’s stock price surged by more than 12% on November 6. Wall Street analysts have a mixed outlook on the stock.

On December 3, Jeffrey Zekauskas from J.P. Morgan reiterated a Hold rating on CC and lowered the price target from $15 to $13. Similarly, on November 28, Hassan Ahmed from Alembic Global lowered the price target from $20 to $19 but maintained a Buy rating on the stock.

During the fiscal Q3 2025, The Chemours Company reported a slight decrease in revenue to $1.50 billion, falling short of expectations by $2.98 million. The EPS of $0.20 also missed analysts’ consensus by $0.04. The company attributed the flat revenue to declines in net sales of Freon Refrigerants and Foam, Propellants & Other, offset by a significant increase in net sales of Opteon™ Refrigerants.

Analysts at Truist Financial noted that the quarterly results reflected demand challenges in Titanium Technologies and industrial markets within Advanced Performance Materials. Despite the weakness, analysts remain confident in management’s efforts to right-size production and preserve cash flow under tough market conditions.

The Chemours Company provides performance chemicals for various markets, including plastics, semiconductors, consumer electronics, coatings, transportation, refrigeration and air conditioning, and general industrial applications.

While CC shows potential as an investment, there are AI stocks that offer greater upside potential with less downside risk. Investors seeking undervalued AI stocks can explore opportunities in the market. For more insights on AI stocks and investment opportunities, check out our free report on the best short-term AI stock.

See also  Travel + Leisure Co. (TNL) Surged Due to the Strengthening of the Value Proposition of the Timeshare Industry

In conclusion, The Chemours Company continues to navigate market challenges and adapt to changing industry dynamics. While the stock has shown resilience in the face of earnings disappointments, investors should carefully consider their investment strategies and evaluate the potential risks and rewards associated with CC.

Disclosure: None. This article was originally published on Insider Monkey.

TAGGED:ChemourscompanyHeresStockStreetThinksWall
Share This Article
Twitter Email Copy Link Print
Previous Article People getting mad in similar ways People getting mad in similar ways
Next Article Tom Ellis and Nick Gehlfuss Make Their CIA Debut in 1st Trailer Tom Ellis and Nick Gehlfuss Make Their CIA Debut in 1st Trailer
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

China state planner lays out further actions to boost economy but no new plans for major stimulus

China's National Development and Reform Commission (NDRC) Chairman, Zheng Shanjie, recently outlined a series of…

October 8, 2024

GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet

This trend of non-persistence with weight loss drugs adds another layer of complexity to the…

January 2, 2025

Jennifer Lawrence Got “Birkin Bangs” For Fall

If you’ve been contemplating bangs this fall, you’re certainly not alone. Jennifer Lawrence recently showcased…

September 29, 2025

Geologic hydrogen: A clean energy source may be lurking beneath mountain ranges

Is there hydrogen to be found beneath the Grisons mountains in Switzerland? Thomas Stoiber /…

May 6, 2025

Judge detains woman accused of using child in insulin scam robberies

Woman Accused of Using Fake Story to Lure Victims and Steal Money A 33-year-old woman…

December 30, 2025

You Might Also Like

The AI Software Story ‘Isn’t Dead.’ Consider This 1 Stock to Buy for 2026 Now.
Economy

The AI Software Story ‘Isn’t Dead.’ Consider This 1 Stock to Buy for 2026 Now.

January 6, 2026
Microsoft Stock Is Entering an ‘Inflection’ Year. What Dan Ives Thinks Is Coming for MSFT.
Economy

Microsoft Stock Is Entering an ‘Inflection’ Year. What Dan Ives Thinks Is Coming for MSFT.

January 6, 2026
Does Bath & Body Works (BBWI) Have Potential for Rapid Growth?
Economy

Does Bath & Body Works (BBWI) Have Potential for Rapid Growth?

January 6, 2026
What You Need To Know Ahead of Quest Diagnostics’ Earnings Release
Economy

What You Need To Know Ahead of Quest Diagnostics’ Earnings Release

January 6, 2026
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?